Cancer trials suspended for new patients
Beth Israel Deaconess Medical Center temporarily closed all its cancer trials to new patients last week, after audits found that several researchers had not properly submitted patient data to the committee that oversees oncology research and to trial sponsors.
“Some of our clinical trials were not running with the high standards that we expect,’’ Randy Mason, vice president of research operations, wrote in an e-mail to hospital executives and physician leaders last week.
He described the lapses as involving documentation and reporting compliance and said the hospital has not found any “issues of patient harm.’’
- 12 Hires to Keep Your Hospital Out of Trouble
- Meaningful Use Payment Adjustments Begin
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Ratcheting Up Patient Experience Has a Downside
- HL20: Lee Aase—Who's Behind @MayoClinic
- 1 in 5 Eligible Hospitals Penalized for HACs
- HL20: Sam Foote, MD—The Courage to Speak Up
- HL20: Derek Angus, MD—An Intense Focus on Care
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- Top 3 Nursing Lessons of 2014